Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update

Go back to Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
(NASDAQ: MIRM) Delayed: 120.89 -6.81 (5.33%)
Previous Close $127.70    52 Week High
Open $126.78    52 Week Low
Day High $127.51    P/E N/A 
Day Low $120.45    EPS
Volume 37,038